Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

Por Swen, J. J., van der Straaten, T., Wessels, J. A. M., Bouvy, M. L., Vlassak, E. E. W., Assendelft, W. J. J., Guchelaar, H.-J.
Publicado em 2011

Myelosuppression by sunitinib is flt-3 genotype dependent

Por van Erp, N P, Mathijssen, R H J, van der Veldt, A A, Haanen, J B, Reyners, A K L, Eechoute, K, Boven, E, Wessels, J A M, Guchelaar, H-J, Gelderblom, H
Publicado em 2010